• 1
    Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, et al. Wound healing is accelerated by agonists of adenosine A2 (Gα s-linked) receptors. J Exp Med 1997; 186: 161520.
  • 2
    Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002; 160: 200918.
  • 3
    Victor-Vega C, Desai A, Montesinos MC, Cronstein BN. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 2002; 26: 1924.
  • 4
    Pillinger MH, Rosenthal PB, Tolani SN, Apsel B, Dinsell V, Greenberg J, et al. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 2003; 171: 60809.
  • 5
    Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967; 18: 26773.
  • 6
    Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 1999; 19: 9192200.
  • 7
    Chen JF, Steyn S, Staal R, Petzer JP, Xu K, Van Der Schyf CJ, et al. 8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. J Biol Chem 2002; 277: 360404.
  • 8
    Markova MS, Zeskand J, McEntee B, Rothstein J, Jimenez SA, Siracusa LD. A role for the androgen receptor in collagen content of the skin. J Invest Dermatol 2004; 123: 10526.
  • 9
    Khoa ND, Montesinos MC, Reiss AB, Delano D, Awadallah N, Cronstein BN. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J Immunol 2001; 167: 402632.
  • 10
    Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, et al. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 2002; 16: 158494.
  • 11
    Vasquez G, Sanhueza F, Vasquez R, Gonzalez M, San Martin R, Casanello P, et al. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 2004; 560: 11122.
  • 12
    Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112: 45662.
  • 13
    Yamamoto T, Eckes B, Krieg T. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res 2000; 292: 55661.
  • 14
    Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 1991; 88: 24415.
  • 15
    Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson LF, Resta R, et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 1998; 101: 295300.
  • 16
    Saransaari P, Oja SS. Enhanced release of adenosine under cell-damaging conditions in the developing and adult mouse hippocampus. Neurochem Res 2003; 28: 140917.
  • 17
    Chen YF, Li PL, Zou AP. Oxidative stress enhances the production and actions of adenosine in the kidney. Am J Physiol Regul Integr Comp Physiol 2001; 281: R180816.
  • 18
    Caporossi D, Ciafre SA, Pittaluga M, Savini I, Farace MG. Cellular responses to H(2)O(2) and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med 2003; 35: 135564.
  • 19
    Slosman DO, Costabella PM, Roth M, Werlen G, Polla BS. Bleomycin primes monocytes-macrophages for superoxide production. Eur Respir J 1990; 3: 7728.
  • 20
    Lower EE, Strohofer S, Baughman RP. Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide. Am J Med Sci 1988; 295: 1937.
  • 21
    Zeidler RB, Yarbro JW, Conley NS. Bleomycin increases superoxide production in the most active alveolar macrophage subpopulation. Int J Immunopharmacol 1987; 9: 6916.
  • 22
    Conley NS, Yarbro JW, Ferrari HA, Zeidler RB. Bleomycin increases superoxide anion generation by pig peripheral alveolar macrophages. Mol Pharmacol 1986; 30: 4852.
  • 23
    Oury TD, Thakker K, Menache M, Chang LY, Crapo JD, Day BJ. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol 2001; 25: 1649.
  • 24
    Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983; 158: 116077.
  • 25
    Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985; 135: 136671.
  • 26
    Cronstein BN, Kubersky SM, Weissmann G, Hirschhorn R. Engagement of adenosine receptors inhibits hydrogen peroxide (H2O2-) release by activated human neutrophils. Clin Immunol Immunopathol 1987; 42: 7685.
  • 27
    Lee HT, Emala CW. Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors. Am J Physiol Renal Physiol 2002; 282: F84452.
  • 28
    Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W, et al. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2004; 287: H247886.
  • 29
    Yamamoto T. Animal model of sclerotic skin induced by bleomycin: a clue to the pathogenesis of and therapy for scleroderma? Clin Immunol 2002; 102: 20916.
  • 30
    Yamamoto T, Nishioka K. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 2005; 14: 8195.
  • 31
    Lakos G, Takagawa S, Varga J. Animal models of scleroderma. Methods Mol Med 2004; 102: 37793.
  • 32
    Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-β/Smad signaling in a murine model of scleroderma. J Invest Dermatol 2003; 121: 4150.
  • 33
    Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol 1992; 126: 5618.
  • 34
    Meunier P, Filipe P, Emerit I, Freitas J, Guerra Rodrigo F, Manso C. Adenosine deaminase in progressive systemic sclerosis. Acta Derm Venereol 1995; 75: 2979.
  • 35
    Sasaki T, Nakajima H. Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. J Am Acad Dermatol 1992; 27: 4114.
  • 36
    Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002; 4: 26673.
  • 37
    Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, Kang MJ, et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 2003; 112: 33244.
  • 38
    Blackburn MR. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 2003; 24: 6670.
  • 39
    Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension 1998; 31: 9438.
  • 40
    Boyle DL, Sajjadi FG, Firestein GS. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 1996; 39: 92330.
  • 41
    Varga J. Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts? Curr Rheumatol Rep 2004; 6: 16470.
  • 42
    Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma: collagen. Rheum Dis Clin North Am 1996; 22: 64774.
  • 43
    Varga J, Bashey RI. Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol 1995; 12: 18799.
  • 44
    Nguyen DK, Montesinos MC, Williams AJ, Kelly M, Cronstein BN. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 2003; 171: 39918.
  • 45
    Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388: 6748.
  • 46
    Chan ESL, Delano DL, Montesinos MC, Pillinger MH, Reiss AB, Friedman SL, et al. Methotrexate-induced hepatic fibrosis: adenosine A(2A) receptor is responsible for hepatic collagen production in vivo and protective effect of caffeine [abstract]. Arthritis Rheum 2002; 46 Suppl 9: S5467.